Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)

v3.19.1
Note 7 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)
9 Months Ended
Mar. 31, 2019
Notes Tables  
Consolidated Stockholders' Equity Statement [Table Text Block]
   
Common Stock
   
Additional
Paid-in
   
Retained
   
Accumulated
Other
Comprehensive
   
 
 
 
   
Shares
   
Amount
   
Capital
   
Earnings
   
Income(Loss)
   
Total
 
Balances at June 30, 2018
 
 
37,608
   
$
376
   
$
246,568
   
$
876,931
   
$
(44,814
)
 
$
1,079,061
 
Cumulative effect adjustments due to adoption of new accounting standards
   
 
     
 
     
 
     
24,780
     
(24,682
)
   
98
 
Net earnings
   
 
     
 
     
 
     
17,403
     
 
     
17,403
 
Other comprehensive loss
   
 
     
 
     
 
     
 
     
(1,136
)
   
(1,136
)
Share repurchases
   
 
     
 
     
 
     
 
     
 
     
-
 
Surrender and retirement of stock to exercise options
   
 
     
 
     
 
     
 
     
 
     
-
 
Common stock issued for exercise of options
   
166
     
2
     
15,609
     
 
     
 
     
15,611
 
Common stock issued for restricted stock awards
   
24
     
0
     
 
     
(1,909
)
   
 
     
(1,909
)
Cash dividends
   
 
     
 
     
 
     
(12,066
)
   
 
     
(12,066
)
Stock-based compensation expense
   
 
     
 
     
11,327
     
 
     
 
     
11,327
 
Common stock issued to employee stock purchase plan
   
5
     
0
     
842
     
 
     
 
     
842
 
Employee stock purchase plan expense
   
 
     
 
     
238
     
 
     
 
     
238
 
Balances at September 30, 2018
 
 
37,803
   
$
378
   
$
274,584
   
$
905,139
   
$
(70,632
)
 
$
1,109,469
 
Net earnings
   
 
     
 
     
 
     
17,556
     
 
     
17,556
 
Other comprehensive loss
   
 
     
 
     
 
     
 
     
(12,379
)
   
(12,379
)
Share repurchases
   
(95
)
   
(1
)
   
 
     
(15,404
)
   
 
     
(15,404
)
Surrender and retirement of stock to exercise options
   
 
     
 
     
 
     
 
     
 
     
-
 
Common stock issued for exercise of options
   
24
     
0
     
2,408
     
 
     
 
     
2,408
 
Common stock issued for restricted stock awards
   
3
     
0
     
 
     
0
     
 
     
-
 
Cash dividends
   
 
     
 
     
 
     
(12,086
)
   
 
     
(12,086
)
Stock-based compensation expense
   
 
     
 
     
6,784
     
 
     
 
     
6,784
 
Common stock issued to employee stock purchase plan
   
0
     
0
     
 
     
 
     
 
     
-
 
Employee stock purchase plan expense
   
 
     
 
     
77
     
 
     
 
     
77
 
Balances at December 31, 2018
 
 
37,735
   
$
377
   
$
283,854
   
$
895,205
   
$
(83,011
)
 
$
1,096,425
 
Net earnings
   
 
     
 
     
 
     
44,654
     
 
     
44,654
 
Other comprehensive income
   
 
     
 
     
 
     
 
     
3,378
     
3,378
 
Share repurchases
   
 
     
 
     
 
     
 
     
 
     
-
 
Surrender and retirement of stock to Exercise options
   
 
     
 
     
 
     
 
     
 
     
-
 
Common stock issued for exercise of Options
   
73
     
1
     
7,336
     
 
     
 
     
7,337
 
Common stock issued for restricted stock Awards
   
1
     
0
     
 
     
 
     
 
     
-
 
Cash dividends
   
 
     
 
     
 
     
(12,086
)    
 
     
(12,086
)
Stock-based compensation expense
   
 
     
 
     
5,640
     
 
     
 
     
5,640
 
Common stock issued to employee stock Purchase plan
   
4
     
0
     
834
     
 
     
 
     
834
 
Employee stock purchase plan expense
   
 
     
 
     
84
     
 
     
 
     
84
 
Balances at March 31, 2019
 
 
37,813 
 
 
378 
 
 
297,748 
 
 
927,773 
 
 
(79,633
 
1,146,266 
 
   
Common Stock
   
Additional
Paid-in
   
Retained
   
Accumulated
Other
Comprehensive
   
 
 
 
   
Shares
   
Amount
   
Capital
   
Earnings
   
Income(Loss)
   
Total
 
Balances at June 30, 2017
 
 
37,356
   
$
374
   
$
199,161
   
$
799,027
   
$
(48,935
)
 
$
949,627
 
Net earnings
   
 
     
 
     
 
     
15,863
     
 
     
15,863
 
Other comprehensive loss
   
 
     
 
     
 
     
 
     
(824
)
   
(824
)
Surrender and retirement of stock to exercise options
   
 
     
 
     
 
     
 
     
 
     
0
 
Common stock issued for exercise of options
   
33
     
0
     
3,051
     
 
     
 
     
3,051
 
Common stock issued for restricted stock awards
   
13
     
0
     
 
     
(227
)
   
 
     
(227
)
Cash dividends
   
 
     
 
     
 
     
(11,958
)
   
 
     
(11,958
)
Stock-based compensation expense
   
 
     
 
     
3,718
     
 
     
 
     
3,718
 
Common stock issued to employee stock purchase plan
   
7
     
0
     
755
     
 
     
 
     
755
 
Employee stock purchase plan expense
   
 
     
 
     
77
     
 
     
 
     
77
 
Balances at September 30, 2017
 
 
37,409
   
$
374
   
$
206,762
   
$
802,705
   
$
(49,759
)
 
$
960,082
 
Net earnings
   
 
     
 
     
 
     
48,847
     
 
     
48,847
 
Other comprehensive loss
   
 
     
 
     
 
     
 
     
(7,058
)
   
(7,058
)
Surrender and retirement of stock to exercise options
   
 
     
 
     
 
     
 
     
 
     
-
 
Common stock issued for exercise of options
   
38
     
1
     
2,892
     
 
     
 
     
2,893
 
Common stock issued for restricted stock awards
   
22
     
0
     
 
     
0
     
 
     
-
 
Cash dividends
   
 
     
 
     
 
     
(11,988
)
   
 
     
(11,988
)
Stock-based compensation expense
   
 
     
 
     
4,985
     
 
     
 
     
4,985
 
Common stock issued to employee stock purchase plan
   
-
     
 
     
-
     
 
     
 
     
-
 
Employee stock purchase plan expense
   
 
     
 
     
59
     
 
     
 
     
59
 
Balances at December 31, 2017
 
 
37,470
   
$
375
   
$
214,697
   
$
839,564
   
$
(56,817
)
 
$
997,819
 
Net earnings
   
 
     
 
     
 
     
19,738
     
 
     
19,738
 
Other Comprehensive Loss
   
 
     
 
     
 
     
 
     
40,956
     
40,956
 
Surrender and retirement of stock to Exercise options
   
 
     
 
     
 
     
 
     
 
     
-
 
Common stock issued for exercise of options
   
68
     
 
     
6,273
     
 
     
 
     
6,273
 
Common Stock issued for restricted stock awards
   
 
     
 
     
 
     
 
     
 
     
-
 
Cash dividends
   
 
     
 
     
 
     
(11,992
)    
 
     
(11,992
)
Stock-based compensation expenses
   
 
     
 
     
4,669
     
 
     
 
     
4,669
 
Common stock issued to employee stock purchase plan
   
7
     
 
     
752
     
 
     
 
     
752
 
Employee stock purchase plan expense
   
 
     
 
     
78
     
 
     
 
     
78
 
Balances at March 31, 2018
 
 
37,545
   
$
375
   
$
226,469
   
$
847,310
   
$
(15,862
)
 
$
1,058,292
 
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
   
Unrealized
   
 
 
 
 
 
 
 
 
 
 
 
   
Gains
   
 
 
 
 
Unrealized
   
 
 
 
   
(Losses) on
   
Foreign
   
Gains
   
 
 
 
   
Available-
   
Currency
   
(Losses) on
   
 
 
 
   
for-Sale
   
Translation
   
Derivatives
   
 
 
 
   
Investments
   
Adjustments
   
Instruments
   
Total
 
Beginning balance as of June 30, 2018
  $
24,682
    $
(69,496
)
  $
-
    $
(44,814
)
Cumulative effect adjustment for adoption for ASU 2018-02
(1)
   
2,371
     
-
     
-
     
2,371
 
Cumulative effect adjustment for adoption for ASU 2016-01
(1)
   
(27,053
)
   
-
     
-
     
(27,053
)
Other comprehensive income (loss), net of tax benefit of $1,792 on derivative instruments
(2)
   
-
     
(4,368
)
   
(5,769
)
   
(10,137
)
Ending balance as of March 31, 2019
  $
-
    $
(73,864
)
  $
(5,769
)
  $
(79,633
)
   
Unrealized
   
 
 
 
 
 
 
 
 
 
 
 
   
Gains
   
 
 
 
 
Unrealized
   
 
 
 
   
(Losses) on
   
Foreign
   
Gains
   
 
 
 
   
Available-
   
Currency
   
(Losses) on
   
 
 
 
   
for-Sale
   
Translation
   
Derivative
   
 
 
 
   
Investments
   
Adjustments
   
Instruments
   
Total
 
Beginning balance as of June 30, 2017
  $
18,989
    $
(67,924
)
  $
-
    $
(48,935
)
Other comprehensive income (loss)
   
22,286
     
10,787
     
-
     
33,073
 
Ending balance as of March 31, 2018
  $
41,275
     
(57,137
)
  $
-
    $
(15,862
)